Menopause Hormone Therapy (HRT) in Brookhaven, GA

Bioidentical hormones in Brookhaven: what it means

"Bioidentical" describes a hormone whose chemical structure matches one the body makes. Two hormones used in menopause care fit it exactly, estradiol and micronized progesterone. Both come in FDA-approved prescription forms, from estradiol pills, patches, gels and vaginal forms to progesterone capsules.

Only 1 OB-GYN lists a primary practice address in Brookhaven in the NPI registry. For 57,224 residents that is 1.7 per 100,000, under the US 17.8 and below Georgia's 17.4. That is about 5,890 women aged 45 to 64 for each OB-GYN in the city, a ratio rather than a count of open appointments.

Counting the area around it, 502 OB-GYNs practice in Brookhaven or within 10 miles and 960 within 25 miles: 23.8 for every 100,000 of the 4,038,581 people who live within 25 miles, a dense supply. Whether or not you have an OB-GYN, you can ask a physician licensed in Georgia about menopause hormone therapy online from Brookhaven, with no waiting room.

"BHRT" often means compounded hormones, a cream, a blend such as Bi-Est or a pellet that a pharmacy mixes for one prescription. They are not FDA-approved, which means the FDA cannot assure their safety or effectiveness. The FDA also says it has no evidence that they are safe and effective, or more effective than approved hormone therapy. A 2020 National Academies review found no rigorous evidence of their safety and effectiveness.

You do not choose a "bioidentical" product from a menu: after a private intake, a physician licensed in Georgia decides what, if anything, fits, and the form. VevaMD does not offer pellets. The pharmacy that fills VevaMD prescriptions also compounds, so ask your physician whether yours is an FDA-approved product or compounded. Two options are compounded for certain: testosterone cream for women and Bi-Est are not FDA-approved.

Then there are pellets, implanted under the skin at a clinic; compounded pellets are not FDA-approved. The Endocrine Society points to a study that found hormone levels well above the expected range in women using them. ACOG advises FDA-approved hormone therapy over compounded preparations.

Sources: FDA: Menopause · FDA: National Academies study of compounded bioidentical hormones (2020) · Endocrine Society position statement on compounded bioidentical hormones (2019) · ACOG Clinical Consensus No. 6, compounded bioidentical menopausal hormone therapy (2023) · CMS NPPES NPI full file, 2026-10-11